This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/drugbank/drug/DB08234/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08234/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08234/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08234/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08234/identifier/pdb/

Statements

Subject Item
n2:DB08234
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08234 n14:DB08234
dcterms:title
5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine
adms:identifier
n6:99444705 n7:N22 n8:25058133 n9:24702741 n10:DB08234
n3:IUPAC-Name
n4:271B4457-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B445D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B445C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4459-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B445A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B445B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4455-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4453-363D-11E5-9242-09173F13E4C5 n4:271B4456-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4454-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4463-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4464-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B445E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B445F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4461-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4460-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4462-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4469-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B446B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B446C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4468-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4467-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B446A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4458-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4465-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4466-363D-11E5-9242-09173F13E4C5